4//SEC Filing
VERNON W ANTHONY 4
Accession 0001562180-23-005017
CIK 0001645113other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:05 PM ET
Size
7.5 KB
Accession
0001562180-23-005017
Insider Transaction Report
Form 4
NovoCure LtdNVCR
VERNON W ANTHONY
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-07+6,277→ 6,277 totalExercise: $48.66From: 2024-06-07Exp: 2033-06-06→ Ordinary Shares (6,277 underlying) - Award
Restricted Stock Units
2023-06-07+3,853→ 165,797 total
Footnotes (2)
- [F1]These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2024 annual general meeting of shareholders.
- [F2]Options to buy 6,277 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2024 annual general meeting of shareholders.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001369091
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:05 PM ET
- Size
- 7.5 KB